Flintix schrieb am 09.12.2021 21:08:
Vergiss es, das interessiert keinen Längszweifler.
Es muss eine Verschwörung sein und kann nicht daran liegen, dass der EMA noch keine Phase 3 Studien vorgelegt wurden, die auch bei einer Zulassung im Rolling Review Verfahren erforderlich ist.
Quelle: EMA
Wollen Sie Bitte folgenden Original Text für das Publikum übersetzen! Oder ist das Verschwörung?
Comirnaty received a conditional marketing authorisation valid throughout the EU on 21 December 2020.
As Comirnaty received a conditional marketing authorisation, the company that markets Comirnaty will continue to provide results from the main trial in adults, which is ongoing for 2 years, as well as from the trials in children. This trial and additional studies will provide information on how long protection lasts, how well the vaccine prevents severe COVID-19, how well it protects immunocompromised people, pregnant women, and whether it prevents asymptomatic cases.
In addition, independent studies of COVID-19 vaccines coordinated by EU authorities will also give more information on the vaccine’s long-term safety and benefit in the general population.
The company will also carry out studies to provide additional assurance on the pharmaceutical quality of the vaccine as the manufacturing continues to be scaled up.